Oncology NSCLC Detection CME
Recent data suggests there is a correlation between lung cancer histologic subtypes and treatment outcomes. Learn how tumor gene expressions can now be used to predict which patients would respond to targeted therapy with this CME activity from Johns Hopkins University School of Medicine.
You will learn how to identify how histologic subtypes of non-small cell cancer (NSCLC) can guide the selection of chemotherapy; develop strategies to individualize therapy based on NSCLC histology, and to determine appropriate maintenance therapy for patients with advanced NSCLC.
To find out how you can better assess your patients in the choice of their chemotherapy treatments go to http://jhasim.com/lungcancer/.
Publication of an advertisement on this site is not to be considered an endorsement or approval by the Texas Medical Association of the product or service involved.
To report inappropriate ads, please email: Classifieds@texmed.org